Managers / Q4 2022 · view latest →
Informed Momentum Co LLC
CIK 0001510989 · 215 HIGHWAY 101, SUITE 216, SOLANA BEACH, CA, 92075 · 7604795075
Summary
Informed Momentum Co LLC reported $483M in U.S.-listed holdings across 249 positions for Q4 2022.
Its largest position, ADMA, represents 1.4% of the portfolio.
Compared with Q3 2022, the fund opened 132 new positions and exited 129.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.9% · $439M
- Other · 9.1% · $44M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VKTXViking Therapeutics Inc | NEW | +494.9K | 494.9K | +$5M | $5M |
| PDSBPDS Biotechnology Corp | NEW | +330.4K | 330.4K | +$4M | $4M |
| KLXEKLX Energy Services Holdings Inc | NEW | +234.9K | 234.9K | +$4M | $4M |
| PARRPar Pacific Holdings Inc | NEW | +142.3K | 142.3K | +$3M | $3M |
| TDWTidewater Inc | NEW | +89.0K | 89.0K | +$3M | $3M |
| Weatherford International PLC | NEW | +62.3K | 62.3K | +$3M | $3M |
| BBWBuild-A-Bear Workshop Inc | NEW | +133.0K | 133.0K | +$3M | $3M |
| PCVXVaxcyte Inc | NEW | +64.8K | 64.8K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ADMAADMA Biologics Inchistory → | Common Stock | 1.41% | $7M | 1.75M |
| 2 | UFPTUFP Technologies Inchistory → | Common Stock | 1.21% | $6M | 49.7K |
| 3 | RYTMRhythm Pharmaceuticals Inc | Common Stock | 0.99% | $5M | 164.7K |
| 4 | VKTXViking Therapeutics Inc | Common Stock | 0.96% | $5M | 494.9K |
| 5 | THTDR Capital LLP | Common Stock | 0.95% | $5M | 304.0K |
| 6 | PDSBPDS Biotechnology Corp | Common Stock | 0.90% | $4M | 330.4K |
| 7 | DGIIDigi International Inc | Common Stock | 0.89% | $4M | 117.7K |
| 8 | CECOCECO Environmental Corp | Common Stock | 0.88% | $4M | 364.0K |
| 9 | KLXEKLX Energy Services Holdings Inc | Common Stock | 0.84% | $4M | 234.9K |
| 10 | ACLXGBXArcellx Inc | Common Stock | 0.82% | $4M | 128.5K |
| 11 | AGYSAgilysys Inc | Common Stock | 0.82% | $4M | 50.0K |
| 12 | MGPIMGP Ingredients Inc | Common Stock | 0.81% | $4M | 37.0K |
| 13 | PIImpinj Inc | Common Stock | 0.81% | $4M | 35.7K |
| 14 | DXLGDestination XL Group Inc | Common Stock | 0.76% | $4M | 542.3K |
| 15 | TMDXTransMedics Group Inc | Common Stock | 0.74% | $4M | 57.9K |
| 16 | ETNBGBP89bio Inc | Common Stock | 0.73% | $4M | 275.9K |
| 17 | HDSNHudson Technologies Inc | Common Stock | 0.73% | $4M | 346.3K |
| 18 | Cymabay Therapeutics Inc | Common Stock | 0.71% | $3M | 550.5K |
| 19 | HROWHarrow Health Inc | Common Stock | 0.71% | $3M | 232.9K |
| 20 | BELFBBel Fuse Inc | Common Stock | 0.71% | $3M | 104.3K |
| 21 | RELLRichardson Electronics Ltd/United States | Common Stock | 0.70% | $3M | 159.7K |
| 22 | ELFelf Beauty Inc | Common Stock | 0.70% | $3M | 60.9K |
| 23 | HURNHuron Consulting Group Inc | Common Stock | 0.70% | $3M | 46.3K |
| 24 | Prometheus Biosciences Inc | Common Stock | 0.69% | $3M | 30.5K |
| 25 | AEHRAehr Test Systems | Common Stock | 0.69% | $3M | 165.1K |
| 26 | PARRPar Pacific Holdings Inc | Common Stock | 0.68% | $3M | 142.3K |
| 27 | TDWTidewater Inc | Common Stock | 0.68% | $3M | 89.0K |
| 28 | GFFGriffon Corp | Common Stock | 0.67% | $3M | 91.1K |
| 29 | EXTRExtreme Networks Inc | Common Stock | 0.67% | $3M | 176.4K |
| 30 | Prothena Corp PLC | Common Stock | 0.67% | $3M | 53.3K |
| 31 | Weatherford International PLC | Common Stock | 0.66% | $3M | 62.3K |
| 32 | BBWBuild-A-Bear Workshop Inc | Common Stock | 0.66% | $3M | 133.0K |
| 33 | PCVXVaxcyte Inc | Common Stock | 0.64% | $3M | 64.8K |
| 34 | EZPWEZCORP Inc | Common Stock | 0.64% | $3M | 378.9K |
| 35 | CTVHelix Energy Solutions Group Inc | Common Stock | 0.64% | $3M | 415.7K |
| 36 | POWLPowell Industries Inc | Common Stock | 0.63% | $3M | 86.5K |
| 37 | UAOSterling Infrastructure Inc | Common Stock | 0.62% | $3M | 91.9K |
| 38 | MODModine Manufacturing Co | Common Stock | 0.62% | $3M | 151.5K |
| 39 | ATENA10 Networks Inc | Common Stock | 0.61% | $3M | 178.2K |
| 40 | MODNEURModel N Inc | Common Stock | 0.61% | $3M | 72.8K |
| 41 | AKROAkero Therapeutics Inc | Common Stock | 0.61% | $3M | 53.5K |
| 42 | PRVBUSDProvention Bio Inc | Common Stock | 0.60% | $3M | 276.3K |
| 43 | VRDNViridian Therapeutics Inc | Common Stock | 0.60% | $3M | 99.6K |
| 44 | CBZCBIZ Inc | Common Stock | 0.59% | $3M | 61.3K |
| 45 | Scorpio Tankers Inc | Common Stock | 0.59% | $3M | 52.9K |
| 46 | LYTSLSI Industries Inc | Common Stock | 0.58% | $3M | 227.0K |
| 47 | DNOWNOW Inc | Common Stock | 0.57% | $3M | 218.0K |
| 48 | SNEXStoneX Group Inc | Common Stock | 0.57% | $3M | 29.0K |
| 49 | CN2Catalyst Pharmaceuticals Inc | Common Stock | 0.57% | $3M | 148.3K |
| 50 | FSSFederal Signal Corp | Common Stock | 0.57% | $3M | 59.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $866M | 273 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $898M | 268 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $872M | 254 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $660M | 220 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $578M | 246 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $706M | 251 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $669M | 239 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $615M | 241 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $642M | 231 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $564M | 232 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $518M | 271 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $540M | 256 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $454M | 248 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $483M | 249 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $460M | 246 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $410M | 245 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $537M | 270 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $610M | 279 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $593M | 274 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $648M | 302 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $664M | 322 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $611M | 292 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $422M | 263 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $452M | 254 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $322M | 205 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $455M | 242 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $378M | 229 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $409M | 242 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $408M | 248 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $368M | 248 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Bank of New York Mellon Corporation028-12592
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.